<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Khera T</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Delirium, an acute decline in attention and global cognitive dysfunction, occurs frequently following cardiac surgery and has been demonstrated to be significantly associated with cognitive dysfunction and reduced functional ability. In the DEXACET trial, we demonstrated a significant reduction in postoperative in-hospital delirium with intravenous (IV) acetaminophen when compared with placebo. In this analysis we examined whether this protective association also extended to 12 month cognitive and functional outcomes. &lt;b>Methods:&lt;/b> This study was a prospective, randomized, placebo-controlled, triple-blinded, factorial design trial conducted at Beth Israel Deaconess Medical Center, approved by the IRB. In this trial, 120 older cardiac surgical patients were randomly ass</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>803903</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8980856</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Twelve-Month Cognitive and Functional Outcomes Following Cardiac Surgery: The DEXACET Trial of Intravenous Acetaminophen Versus Placebo.</pubmed_title><pmcid>PMC8980856</pmcid><pubmed_authors>Khera T</pubmed_authors><pubmed_authors>Helfand J</pubmed_authors><pubmed_authors>Shankar P</pubmed_authors><pubmed_authors>Marcantonio ER</pubmed_authors><pubmed_authors>Kelly L</pubmed_authors><pubmed_authors>Mueller A</pubmed_authors><pubmed_authors>Subramaniam B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Twelve-Month Cognitive and Functional Outcomes Following Cardiac Surgery: The DEXACET Trial of Intravenous Acetaminophen Versus Placebo.</name><description>&lt;b>Background:&lt;/b> Delirium, an acute decline in attention and global cognitive dysfunction, occurs frequently following cardiac surgery and has been demonstrated to be significantly associated with cognitive dysfunction and reduced functional ability. In the DEXACET trial, we demonstrated a significant reduction in postoperative in-hospital delirium with intravenous (IV) acetaminophen when compared with placebo. In this analysis we examined whether this protective association also extended to 12 month cognitive and functional outcomes. &lt;b>Methods:&lt;/b> This study was a prospective, randomized, placebo-controlled, triple-blinded, factorial design trial conducted at Beth Israel Deaconess Medical Center, approved by the IRB. In this trial, 120 older cardiac surgical patients were randomly ass</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-05-29T19:47:30.705Z</modification><creation>2025-05-29T19:47:30.705Z</creation></dates><accession>S-EPMC8980856</accession><cross_references><pubmed>35392551</pubmed><doi>10.3389/fphar.2022.803903</doi></cross_references></HashMap>